Prime Medicine Inc. (PRME)
NASDAQ: PRME
· Real-Time Price · USD
3.62
-0.02 (-0.55%)
At close: Aug 15, 2025, 12:50 PM
Prime Medicine Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -52.59M | -51.89M | -42.28M | -52.52M | -55.33M | -45.76M | -65.64M | -50.71M | -42.38M | -39.4M | -39.28M | -29.35M | -29.35M | -23.84M | -62.91M | -16.41M | 616K | -86.66M |
Depreciation & Amortization | 1.45M | 1.54M | 1.72M | 1.56M | 1.54M | 1.31M | 1.25M | 1.24M | 1.12M | 1.05M | 870K | 631K | 430K | 293K | 229K | 167K | 122K | 50K |
Stock-Based Compensation | 6.33M | 5.68M | 5.94M | 6.83M | n/a | 5.21M | 4.43M | 4.22M | 3.58M | 1.68M | 2.57M | 1.42M | 1.34M | 1.12M | 1.11M | 339K | 94K | 206K |
Other Working Capital | 9.52M | -9.52M | 46.4M | 2.06M | -1.4M | -24.23M | 12.17M | -3.36M | -7.19M | 504K | 740K | -3.45M | 185K | -35.34M | 31.48M | -905K | -707K | 122K |
Other Non-Cash Items | -4.25M | 3.31M | 2M | 14.64M | 13.18M | 15.23M | 6.3M | 3.8M | 2.42M | 3.92M | 4.16M | 840K | 6.23M | 6.45M | 15.58M | 9.45M | -6.54M | 81.41M |
Deferred Income Tax | n/a | n/a | n/a | n/a | -134K | 134K | -4.64M | -108K | 31K | -202K | -202K | 212K | -442K | -532K | 1.24M | -2.37M | n/a | n/a |
Change in Working Capital | 7.65M | -7.65M | 48.86M | 3.58M | -4.75M | -30.11M | 14.45M | 2.4M | -5.59M | -8.62M | 1.17M | -3.85M | 1.57M | -34.29M | 31.56M | -780K | -707K | 122K |
Operating Cash Flow | -41.41M | -48.86M | 16.25M | -25.91M | -45.49M | -67.71M | -43.86M | -39.17M | -40.82M | -41.56M | -30.71M | -30.1M | -20.22M | -50.79M | -13.19M | -9.61M | -6.41M | -4.88M |
Capital Expenditures | -1.57M | -2.42M | -1.79M | -1.28M | -1.9M | -2.32M | -1.84M | -2.91M | -1.98M | -2M | -4.81M | -4.79M | -4.8M | -1.69M | -382K | -1.82M | -926K | -1.02M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | -43.13K | 34.86K | n/a | 10.67K | n/a | 8.72K | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -6.91M | -48.32M | 16.87M | -10.4M | -28.7M | -107.21M | -4.41M | -54.88M | 7K | -45.67M | -33.87M | -14.72M | -74.74M | n/a | -139K | -5.92M | n/a | n/a |
Sales Maturities Of Investments | 11.25M | 3M | 32.9M | 61.3M | 37.5M | 72.5M | 47.53M | 20.02M | 30M | 35M | 25M | 6M | 29.5M | 32.5M | 13M | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | 276K | 724K | n/a | -34.71M | 43.13K | -34.86K | -170K | -10.67K | -1K | -8.72K | -745K | 81K | -325K | 108K | -76.25M | 46K |
Investing Cash Flow | 2.77M | -47.74M | 48.25M | 50.34M | 6.89M | -37.03M | 41.28M | -37.77M | 27.86M | -12.66M | -13.69M | -13.51M | -50.79M | 30.89M | 12.15M | -7.64M | -77.17M | -972K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 197K | 6M | 1K | 432K | 35K | 25.27M | 194K | 318K | 75K | 68K | -1.18M | -746K | -624K | -1.27M | -1.09M | n/a | 268.05M | 2.31M |
Financial Cash Flow | 197K | 6M | 1K | 38.51M | 35K | 157.33M | 194K | 318K | 75K | 68K | 184.07M | -683K | -624K | -1.27M | -1.09M | -1K | 268.05M | 2.31M |
Net Cash Flow | -38.44M | -90.6M | 64.5M | 62.94M | -38.56M | 52.59M | -2.38M | -76.62M | -12.88M | -54.16M | 139.67M | -44.29M | -71.64M | -21.17M | -2.12M | -17.24M | 184.47M | -3.54M |
Free Cash Flow | -42.98M | -51.28M | 14.45M | -27.19M | -47.39M | -70.03M | -45.7M | -42.08M | -42.8M | -43.56M | -35.53M | -34.89M | -25.02M | -52.48M | -13.57M | -11.43M | -7.34M | -5.89M |